Austin D. Kim - Net Worth and Insider Trading

Austin D. Kim Net Worth

The estimated net worth of Austin D. Kim is at least $841,404 dollars as of 2024-11-13. Austin D. Kim is the EVP,General Counsel, Secretary of ACADIA Pharmaceuticals Inc and owns about 46,901 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $841,404. Details can be seen in Austin D. Kim's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Austin D. Kim has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Austin D. Kim

To

Austin D. Kim Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Austin D. Kim owns 1 companies in total, including ACADIA Pharmaceuticals Inc (ACAD) .

Click here to see the complete history of Austin D. Kim’s form 4 insider trades.

Insider Ownership Summary of Austin D. Kim

Ticker Comapny Transaction Date Type of Owner
ACAD ACADIA Pharmaceuticals Inc 2024-01-08 EVP & General Counsel

Austin D. Kim Latest Holdings Summary

Austin D. Kim currently owns a total of 1 stock. Austin D. Kim owns 46,901 shares of ACADIA Pharmaceuticals Inc (ACAD) as of January 8, 2024, with a value of $841,404.

Latest Holdings of Austin D. Kim

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACAD ACADIA Pharmaceuticals Inc 2024-01-08 46,901 17.94 841,404

Holding Weightings of Austin D. Kim


Austin D. Kim Form 4 Trading Tracker

According to the SEC Form 4 filings, Austin D. Kim has made a total of 15 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 590 shares on January 8, 2024, which brought Austin D. Kim around $17,676.

Insider Trading History of Austin D. Kim

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Austin D. Kim Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Austin D. Kim Ownership Network

Ownership Network List of Austin D. Kim

No Data

Ownership Network Relation of Austin D. Kim

Insider Network Chart

Austin D. Kim Owned Company Details

What does ACADIA Pharmaceuticals Inc do?

Who are the key executives at ACADIA Pharmaceuticals Inc?

Austin D. Kim is the EVP & General Counsel of ACADIA Pharmaceuticals Inc. Other key executives at ACADIA Pharmaceuticals Inc include EVP & COO & Head of Commercial Brendan Teehan , Chief Financial Officer Mark C. Schneyer , and director & PRESIDENT AND CEO Stephen Davis .

ACADIA Pharmaceuticals Inc (ACAD) Insider Trades Summary

Over the past 18 months, Austin D. Kim made 2 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net sale of 16,959. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 54,525 shares made by Mark C. Schneyer , a net sale of 319,936 shares made by Stephen Davis , and a net sale of 41,903 shares made by Brendan Teehan .

In summary, during the past 3 months, insiders sold 51,014 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 0 shares, with a net sale of 51,014 shares. During the past 18 months, 455,345 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 441,177 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ACADIA Pharmaceuticals Inc Insider Transactions

No Available Data

Austin D. Kim Mailing Address

Above is the net worth, insider trading, and ownership report for Austin D. Kim. You might contact Austin D. Kim via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.